awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34805650-AA1144C0-D6AB-4532-B7A0-A52B7B11D95D
Q34805650-AA1144C0-D6AB-4532-B7A0-A52B7B11D95D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34805650-AA1144C0-D6AB-4532-B7A0-A52B7B11D95D
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS S
P2860
Q34805650-AA1144C0-D6AB-4532-B7A0-A52B7B11D95D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34805650-AA1144C0-D6AB-4532-B7A0-A52B7B11D95D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61ef56f09d480e8068464c2ed41ee37a9eb0cde7
P2860
MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.